§ Player · Forward

Chidera Ejuke

Sevilla

In the 2025-26 La Liga, Chidera Ejuke has an NVP of 35: number 80 of 101 forwards in the league with 900+ minutes.

They produce 1.23 times their position's average and cost 1.57 times as much.

Their strongest skill is Defender: S, percentile 100.

They have a rating in 17 matches that season and were player of the match in 0. Their best rating was 60, in FC Barcelona 5–2 Sevilla.

Seasons

SeasonCompetitionTeamMinGAProducesCostsNVP
2025-26 La Liga Sevilla 92411 1.23× 1.57× 35
2024-25 La Liga Sevilla 95821 1.26× 1.10× 51

Skills

Percentile against players in the same position in the 2025-26 La Liga, as on the app card.

StrikerX13
CreatorC55
DribblerA92
DefenderS100
ControlA88

Latest matches

  1. 27 Sevilla 1–3 FC Barcelona19 Sep · La Liga · 31'
  2. 42 Sevilla 1–0 Valencia11 Sep · La Liga · 27'
  3. 54 Espanyol 1–1 Sevilla6 Sep · La Liga · 60'
  4. 48 Sevilla 1–3 Atlético de Madrid29 Aug · La Liga · 35'
  5. 59 Athletic Club 1–3 Sevilla22 Aug · La Liga · 44'
  6. 47 Sevilla 0–1 Real Madrid17 May · La Liga · 36'
  7. 52 Sevilla 2–1 Espanyol9 May · La Liga · 90'
  8. 47 Sevilla 1–0 Real Sociedad4 May · La Liga · 90'
  9. 60 FC Barcelona 5–2 Sevilla15 Mar · La Liga · 44'
  10. 60 Sevilla 1–1 Rayo Vallecano8 Mar · La Liga · 23'

Best matches

  1. 69 Real Sociedad 0–1 Sevilla9 Mar 2025 · La Liga
  2. 63 Sevilla 2–1 Real Valladolid24 Sep 2024 · La Liga
  3. 61 Rayo Vallecano 1–1 Sevilla1 Mar 2025 · La Liga
  4. 60 Sevilla 1–2 Villarreal23 Sep 2025 · La Liga
  5. 60 Sevilla 1–1 Rayo Vallecano8 Mar 2026 · La Liga

How is the rating calculated?

The rating measures a single match: what the player produced against what they cost, compared with the average for their position in that league and season, and adjusted by position (a 70 for a forward is as hard to get as a 70 for a defender). A normal match is around 50, 70 is already very good and only one in a hundred goes above 80. It is not the NVP, which ranks the whole season.

See their card in La Lente All their metrics, recent form, comparisons and Same DNA.